- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
Cardiovascular Risk Assessment
29 - 30 June 2010
|
Cardiovascular Risk Assessment
Exploring the latest updates in QT prolongation, biomarkers, blood pressure and other CV related safety issues
Informa Life Sciences’ Cardiovascular Risk Assessment has been specifically designed to reflect the latest scientific and technological breakthroughs for assessing cardiac risk in both the preclinical and clinical environment. From overcoming the difficulties of QT assessment for drugs which affect the heart rate, novel methodologies for oncology & diabetes safety assessment to biomarkers to predict cardiotoxicity. Dealing with ion channel liabilities to limits allowed for blood pressure changes.
Join us this June to benchmark your cardiac safety testing programmes against leading global industry representatives, reducing your exposure to liabilities and avoiding costly drug failures due to cardiac risk.
Highlights of Cardiovascular Risk Assessment 2010
Brand new topics for 2010
Our 2010 Expert Speaker Faculty Includes:
Our 2010 Expert Speaker Faculty Includes:
Corina-Dana Dota, MD
AZ ECG Centre Director,
AstraZeneca R&D
|
Marek Malik
Professor of Cardiac Electrophysilogy
St George's University of London
|
Mary Jane Geiger
Senior Medical Advisor
Eli Lilly & Company
|
Philip T. Sager
VP, Clinical Research Head
Gilead Sciences,Inc.
|
Martin Traebert
Group Head of Safety Pharmacology
Novartis
|
Bérengère Dumotier,
Preclinical Cardio Safety Expert,
Novartis
|
Jianguo(James) Li
Director of Clinical Pharmacology,
AstraZeneca
|
Borje Darpo
Associated Professor of Cardiology,
Pharmaceutical Consultant
|
Sponsors
Media Partners
Dates and Venues
29 Jun 2010 - 30 Jun 2010
Renaissance Zurich Hotel
Our expert speaker panel is made up of representatives from:
Those who attend include Directors, Managers, Team Leaders and Project Leaders of:
Safety, Metabolomics, Toxicology, Functional validation, Genomics,
Pharmacology, QT, ECG studies, Cardiac Safety, Drug Safety, DMPK,
ADME, Pre-clinical Safety, Data Management and DILI
AND Specialists/Senior Scientists working in:
Drug Safety and Surveillance, Drug Metabolism, Pharmacokinetics,
Proteomics, Pharmacogenetics, Immunoglogy, Bioinformatics,
Pharmacovigilance, Toxicology, Genetics, Modelling and Simulation,
Clinical & Pre-Clinical Pharmacology, Automated Biotechnology,
Medical Science, Product Safety, Drug Development and Clinical
Research, Regulatory Affairs, Quality Assurance
Feeds | Like | Share    |
Sponsor
Media Partners